suPARnostic® is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum.

suPAR is a universal and broadly applicable prognostic biomarker of chronic inflammation and immune activation across diseases. suPAR can identify inflammation and immune activation to aid in determining the risk of patient outcomes.

Significant clinical benefits include:

  • Identification of patients who can be safely discharged after treatment
  • Helps to prioritize patients and reduce Emergency Department crowding
  • Add to clinical decisions
  • Identification of high-risk patients with unaffected vital signs

suPARnostic® also improves the efficiency of the Emergency Department by shortening the average patient-length-of-stay, which leads to cost savings.

Want to buy suPARnostic®?


published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution


For Automated Systems


Clinical and Research

suPARnostic POC+


Point-of-care finger prick

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates